Fish oil administration in older adults: Is there potential for adverse events? A systematic review of the literature

BMC Geriatrics

Volumn 13, Issue 1, 2013, Pages

  Villani, Anthony M ^a   Crotty, Maria ^a   Cleland, Leslie G ^b   James, Michael J ^b   Fraser, Robert J ^a   Cobiac, Lynne ^a   Miller, Michelle D ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Adverse events; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Older adults

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

AGED; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DOSE RESPONSE; GASTROINTESTINAL DISEASE; HUMAN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FISH OILS; GASTROINTESTINAL DISEASES; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876783447     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-13-41     Document Type: Review

References (58)

1. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Calder PC, Biochimie 2009 91 791 795 10.1016/j.biochi.2009.01.008 19455748
2. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Goldberg RJ, Katz J, Pain 2007 129 210 223 10.1016/j.pain.2007.01.020 17335973 (Pubitemid 46551386)
3. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease (Review). Turner D, Zlotkin S, Shah P, Griffiths A, Cochrane Database Syst Rev 2007 2 1 18
4. Review: the role of omega 3 fatty acids in intestinal inflammation. Teitelbaum JE, Allan Walker W, J Nutr Biochem 2001 12 21 32 10.1016/S0955- 2863(00)00141-8 11179858 (Pubitemid 32120193)
5. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. MacLean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, Tu W, Hilton LG, Gralnek IM, Rhodes S, Khanna P, Am J Clin Nutr 2005 82 611 619 16155275
6. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review. Nettleton JA, Katz R, JADA 2005 105 428 440 10.1016/j.jada.2004.11.029 (Pubitemid 40326734)
7. Dietary fat intake and prevention of cardiovascular disease: systematic review. Hooper L, Summerbell CD, Higgins JPT, Thompson RL, Capps NE, Smith GD, Riemersma RA, Ebrahim S, BMJ 2001 322 757 763 10.1136/bmj.322.7289.757 11282859 (Pubitemid 32269648)
8. n-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J, Am J Clin Nutr 2006 84 5 17 16825676 (Pubitemid 44699166)
9. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JPT, Capps NE, BMJ 2006 332 752 760 10.1136/bmj.38755.366331.2F 16565093 (Pubitemid 44365649)
10. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Dewey A, Baughan C, Dean T, Higgins B, Johnson I, Cochrane Database Syst Rev 2007 1 1 27
11. Dietary reference intakes for DHA and EPA. Kris-Etherton PM, Grieger JA, Etherton TD, Prost Leuk Ess Fatty Acids 2009 81 99 104 10.1016/j.plefa.2009.05. 011
12. Australia and New Zealand National Health and Medical Research Council, Nutrient reference values for Australia and New Zealand including recommended dietary intakes Australian Government: Department of Health and Ageing Reference no: N35, N36, N37, N38, N264, N265 2006
13. National Heart Foundation of Australia, Review of the evidence: Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health 2008 1 7
14. Australian adults use complementary and alternative medicine in the treatment of chronic illness: a national study. Armstrong AR, Thiébaut SP, Brown LJ, Nepal B, Aust New Zeal J Public Health 2011 35 384 390 10.1111/j.1753-6405.2011.00745.x
15. Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. Goh L, Vitry A, Semple S, Esterman A, Luszcz M, BMC Complem Altern Med 2009 9 1 10 10.1186/1472-6882-9-1
16. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH, Postgrad Med J 2009 85 84 90 10.1136/pgmj.2008.073338 19329703
17. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. Ruxton CHS, Reed SC, Simpson MJA, Millington KJ, J Hum Nutr Dietet 2004 17 449 459 10.1111/j.1365-277X.2004.00552.x (Pubitemid 39307100)
18. Polyunsaturated fatty acids, inflammation, and immunity. Calder P, Lipids 2001 36 1007 1024 10.1007/s11745-001-0812-7 11724453 (Pubitemid 33065203)
19. Dietary fatty acids and the immune system. Calder P, Lipids 1999 34 137 S140 10.1007/BF02562264 10419124
20. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Calder PC, Am J Clin Nutr 2006 83 1505 1519S
21. Cardiovascular effects of marine omega-3 fatty acids. Saravanan P, Davidson NC, Schmidt EB, Calder PC, Lancet 2010 376 540 550 10.1016/S0140- 6736(10)60445-X 20638121
22. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. Knapp HR, Reilly IAG, Alessandrini P, FitzGerald GA, New Eng J Med 1986 314 937 942 10.1056/NEJM198604103141501 3007982 (Pubitemid 16129827)
23. n-3 polyunsaturated fatty acids and coronary thrombosis. Kristensen S, Bach Iversen A, Schmidt E, Lipids 2001 36 79 S82 10.1007/s11745-001-0686-8 11837997
24. Safety considerations with omega-3 fatty acid therapy. Bays HE, Am J Cardiol 2007 99 35 S43 10.1016/j.amjcard.2006.11.020 (Pubitemid 46412230)
25. Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature. McClaskey E, Michalets E, J Human Pharmacol Drug Therapy 2007 27 152 160 10.1592/phco.27.1.152 (Pubitemid 46067970)
26. Fish oil interaction with warfarin. Buckley MS, Goff AD, Knapp WE, Ann Pharmacother 2004 38 50 53 14742793 (Pubitemid 38018005)
27. Safety of fish oil and omega-3 fatty acids. Turner M, Medicines Safety Update 2010 2 48 52
28. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95) 00134-4 8721797 (Pubitemid 26120810)
29. Influence of very low dietary intake of marine oil on some functional aspects of immune cells in healthy elderly people. Bechoua S, Dubois M, Vericel E, Chapuy P, Lagarde M, Prigent A, BJN 2003 89 523 531 10.1079/BJN2002805 (Pubitemid 36582123)
30. The influence of low intake of n-3 fatty acids on platelets in elderly people. Véricel E, Calzada C, Chapuy P, Lagarde M, Atherosclerosis 1999 147 187 192 10.1016/S0021-9150(99)00171-9 10525140 (Pubitemid 29486788)
31. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC, Am J Clin Nutr 2001 73 539 548 11237929 (Pubitemid 32176504)
32. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC, J Nutr 2001 131 1918 1927 11435508 (Pubitemid 32661059)
33. Reduced prostaglandin F§ssub§2α§esub§ release from blood mononuclear leukocytes after oral supplementation of n-3 fatty acids: the OmegAD study. Vedin I, Cederholm T, Freund-Levi Y, Basun H, Hjorth E, Irving GF, Eriksdotter-Jonhagen M, Schultzberg M, Wahlund L-O, Palmblad J, J Lipid Research 2010 51 1179 1185 10.1194/jlr.M002667
34. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, Faxen-Irving G, Eriksdotter-Jonhagen M, Vessby B, Wahlund L-O, Palmblad J, Am J Clin Nutr 2008 87 1616 1622 18541548 (Pubitemid 351872622)
35. Omega-3 fatty acid treatment in 174 patients with mild to moderate alzheimer disease: omegAD study: a randomized double-blind trial. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund L-O, Palmblad J, Arch Neurol 2006 63 1402 1408 10.1001/archneur.63.10.1402 17030655 (Pubitemid 44547551)
36. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a Randomized, Double-blind, PLacebo-Controlled Trial. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, OldeRikkert MGM, Beekman ATF, de Groot CPGM, J Am Geriatr Soc 2009 57 1481 1486 10.1111/j.1532-5415.2009.02361.x 19549020
37. Effect of fish oil on cognitive performance in older subjects. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, OldeRikkert MGM, Beekman ATF, de Groot LC, Neurology 2008 71 430 438 10.1212/01.wnl.0000324268. 45138.86 18678826
38. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, de Groot LC, Am J Clin Nutr 2008 88 706 713 18779287
39. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, Müller M, Afman LA, Am J Clin Nutr 2009 90 415 424 10.3945/ajcn.2009.27680 19515734
40. Effect of omega-3 fatty acid supplementation on depressive symptoms and on health-related quality of Life in the treatment of elderly women with depression: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, Montorfano G, Negroni M, Berra B, Politi P, Rizzo AM, J Am Coll Nutr 2010 29 55 64 20595646
41. Nutritional AMD treatment phase I (NAT-1): feasibility of oral DHA supplementation in age-related macular degeneration. Querques G, Benlian P, Chanu B, Portal C, Coscas G, Soubrane G, Souied E, Euro J Ophthalmology 2009 19 100 106
42. Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis. Gruenwald J, Petzold E, Busch R, Petzold HP, Graubaum H-J, Adv Ther 2009 26 858 871 10.1007/s12325-009-0060-3 19756416
43. The effects of low dose n-3 fatty acids on serum lipid profiles and Insulin resistance of the elderly: a Randomized Controlled Clinical Trial. Fakhrzadeh H, Ghaderpanahi M, Sharifi F, Mirarefin M, Badamchizade Z, Akbari Kamrani A, Larijani B, Int J Vitam Nutr Res 2010 80 107 116 10.1024/0300-9831/ a000011 20803425
44. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Holguin F, Téllez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernández M, Romieu I, Chest 2005 127 1102 1107 10.1378/chest.127.4.1102 15821181 (Pubitemid 46224267)
45. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B, Am J Clin Nutr 2011 93 402 412 10.3945/ajcn.110.005611 21159787
46. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Thies F, Miles E, Nebe-von-Caron G, Powell J, Hurst T, Newsholme E, Calder P, Lipids 2001 36 1183 1193 10.1007/s11745-001-0831-4 11795850 (Pubitemid 34007971)
47. Expert Opinion: Omega-3 fatty acids and bleeding-cause for concern? Harris WS, Am J Cardiol 2007 99 44 S46
48. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel-versus-aspirin + clopidogrel in patients with cardiovascular disease. Watson PD, Joy PS, Nkonde C, Hessen SE, Karalis DG, Am J Cardiol 2009 104 1052 1054 10.1016/j.amjcard.2009.05.055 19801023
49. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Eslick GD, Howe P, Smith C, Priest R, Bensoussan A, Int J Cardiol 2009 136 4 16 10.1016/j.ijcard.2008.03.092 18774613
50. A systemic review of the roles of n-3 fatty acids in health and disease. Riediger ND, Othman RA, Suh M, Moghadasian MH, JADA 2009 109 668 679 10.1016/j.jada.2008.12.022
51. Plant and marine derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM, Am J Clin Nutr 2003 77 783 795 12663273
52. Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes. Pedersen H, Petersen M, Major-Pedersen A, Jensen T, Nielsen NS, Lauridsen S, Marckmann P, Eur J Clin Nutr 2003 57 713 720 10.1038/sj.ejcn.1601602 12771973 (Pubitemid 36626347)
53. Fish intake, contaminants, and human health. Mozaffarian D, Rimm EB, JAMA 2006 296 1885 1899 10.1001/jama.296.15.1885 17047219
54. Fish oil: what the prescriber needs to know. Cleland L, James M, Proudman S, Arthritis Res Ther 2006 8 1 9
55. Omega 3 fatty acids and cognitive health in older people. Dangour AD, Andreeva VA, Sydenham E, Uauy R, Br J Nutr 2012 107 S2 152 S158 10.1017/S0007114512001547 22591889
56. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, Rae DE, West S, Dugas J, Dugas L, Meltzer S, BJN 2007 97 1001 1011 10.1017/S0007114507172822 (Pubitemid 46554416)
57. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators. Brouwer IA, Zock PL, Camm AJ, Böcker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, JAMA 2006 295 2613 2619 10.1001/jama.295.22.2613 16772624 (Pubitemid 43882336)
58. Testing the acceptability of liquid fish oil in older adults. Yaxley A, Miller MD, Fraser RJ, Cobiac L, Crotty M, Asia Pac J Clin Nutr 2011 20 175 179 21669585